NASDAQ:ACON Aclarion (ACON) Stock Price, News & Analysis $2.38 -0.06 (-2.46%) Closing price 10/2/2026 04:00 PM EasternExtended Trading$2.37 -0.01 (-0.34%) As of 10/2/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and TrendsSEC Filings About Aclarion Stock (NASDAQ:ACON) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Aclarion alerts:Sign Up Key Stats Today's Range$2.35▼$2.4750-Day Range$2.02▼$2.9452-Week Range$1.95▼$12.03Volume15,749 shsAverage Volume47,315 shsMarket Capitalization$6.85 millionP/E RatioN/ADividend YieldN/APrice Target$7.50Consensus RatingHold Company Overview Aclarion, Inc. (NASDAQ: ACON) is a healthcare technology company focused on improving the diagnosis and treatment of chronic low back pain. The company develops tools intended to help physicians identify the spinal discs that may be contributing to a patient’s pain and support more informed treatment decisions. Its principal product, Nociscan, is a cloud-based platform that analyzes data from magnetic resonance spectroscopy (MRS) and magnetic resonance imaging (MRI). By combining imaging information with proprietary algorithms and biochemical biomarkers, the platform is designed to provide physicians with additional objective information about disc health and potential pain generators. Aclarion was formerly known as Nocimed and adopted the Aclarion name as it expanded its focus on data-driven spine care. The company markets its technology to healthcare providers and spine specialists in the United States and internationally. Its solutions are intended to complement, rather than replace, clinical evaluation and existing diagnostic imaging.AI Generated. May Contain Errors. Read More Aclarion Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks57th Percentile Overall ScoreACON MarketRank™: Aclarion scored higher than 57% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingAclarion has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialAclarion has a consensus price target of $7.50, representing about 215.1% upside from its current price of $2.38.Amount of Analyst CoverageAclarion has only been the subject of 1 research reports in the past 90 days.Read more about Aclarion's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Aclarion are expected to decrease in the coming year, from ($4.51) to ($5.37) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aclarion is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aclarion is -0.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAclarion has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aclarion's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.64% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 1.94, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently increased by 206.89%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAclarion does not currently pay a dividend.Dividend GrowthAclarion does not have a long track record of dividend growth. News and Social Media1.3 / 5News Sentiment0.09 News SentimentAclarion has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.47 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Aclarion this week, compared to 3 articles on an average week. Company Ownership3.7 / 5Insider TradingAcquiring Shares Cluster Insider Buying6 insiders have purchased shares of Aclarion in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $125,670.00 in company stock, which represents 1.8334% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Aclarion insiders have bought more of their company's stock than they have sold. Specifically, they have bought $125,670.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.01% of the stock of Aclarion is held by insiders.Percentage Held by Institutions7.52% of the stock of Aclarion is held by institutions.Read more about Aclarion's insider trading history. Receive ACON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACON Stock News HeadlinesHealth Catalyst (NASDAQ:HCAT) and Aclarion (NASDAQ:ACON) Critical AnalysisOctober 3 at 4:58 AM | americanbankingnews.comAclarion (NASDAQ:ACON) versus Veeva Systems (NYSE:VEEV) Financial AnalysisOctober 2 at 5:29 AM | americanbankingnews.comSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely. | Altimetry (Ad)Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven SitesSeptember 29, 2026 | globenewswire.comAclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial SiteAugust 20, 2026 | globenewswire.comTop Aclarion Executive Makes Bold Insider Move on Company StockAugust 18, 2026 | tipranks.comAclarion Receives USPTO Notice of Allowance for Patent Covering Multi-Voxel Prescription for Lumbar Disc EvaluationAugust 12, 2026 | quiverquant.comQAclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan ProcessAugust 12, 2026 | globenewswire.comSee More Headlines ACON Stock Analysis - Frequently Asked Questions How have ACON shares performed this year? Aclarion's stock was trading at $4.60 on January 1st, 2026. Since then, ACON stock has decreased by 48.3% and is now trading at $2.38. How were Aclarion's earnings last quarter? Aclarion, Inc. (NASDAQ:ACON) released its quarterly earnings results on Thursday, August, 6th. The company reported ($1.12) earnings per share for the quarter, missing the consensus estimate of ($1.05) by $0.07. The company earned $0.03 million during the quarter, compared to analyst estimates of $0.03 million. Aclarion had a negative trailing twelve-month return on equity of 59.34% and a negative net margin of 10,948.81%. When did Aclarion's stock split? Aclarion shares reverse split on the morning of Friday, March 28th 2025.The 1-27 reverse split was announced on Wednesday, March 26th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, March 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How will Aclarion's stock buyback program work? Aclarion's Board of Directors authorized a share buyback plan on Wednesday, April 22nd 2026, which allows the company to repurchase $2,500,000 in outstanding shares, according to EventVestor. This means that the company could buy up to 31% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued. When did Aclarion IPO? Aclarion (ACON) raised $12 million in an initial public offering on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share. How do I buy shares of Aclarion? Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aclarion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aclarion investors own include Broadcom (AVGO), Meta Platforms (META), Norwegian Cruise Line (NCLH), Audioeye (AEYE), Advanced Micro Devices (AMD), ASML (ASML) and AvidXchange (AVDX). Company Calendar Last Earnings8/06/2026Today10/04/2026Next Earnings (Estimated)11/11/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (31m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ACON's financial health is in the Red zone, according to TradeSmith. ACON has been in this zone for over 31 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:ACON CIK1635077 Webwww.aclarion.com Phone833-275-2266FaxN/AEmployees11Year Founded2008Price Target and Rating Average Price Target for Aclarion$7.50 High Price Target$7.50 Low Price Target$7.50 Potential Upside/Downside+215.1%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($7.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.23 million Net Margins-10,948.81% Pretax Margin-10,950.00% Return on Equity-59.34% Return on Assets-56.12% Debt Debt-to-Equity RatioN/A Current Ratio16.19 Quick Ratio16.19 Sales & Book Value Annual Sales$80 thousand Price / Sales85.68 Cash FlowN/A Price / Cash FlowN/A Book Value$15.02 per share Price / Book0.16Miscellaneous Outstanding Shares2,880,000Free Float2,882,000Market Cap$6.85 million OptionableNot Optionable Beta1.20 Social Links 10 Best Stocks to Own in Fall 2026AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.Get This Free Report This page (NASDAQ:ACON) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersLarry's Three-Step Strategy Revealed at The Dollar Trap SummitLarry unveiled a three-step strategy at last night's Dollar Trap Summit, with no options, futures, or cryptocu...Brownstone Research | SponsoredElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredA major gold reset could be closer than people thinkFor 50 years, Washington has held 8,133 tonnes of gold on its books at a fraction of today's market price. One...Reagan Gold Group | SponsoredNew Chip takes minutes, not daysGeorge Gilder believes today's AI data centers could become tomorrow's typewriters - replaced by a single wafe...Eagle Publishing | SponsoredThe case for $20,000 gold before year endPresident Trump reposted a warning from precious metals expert Jim Rickards, tying the November midterms and A...Stansberry Research | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
